Platelet decline: An avenue for investigation into the pathogenesis of human immunodeficiency virus-associated dementia

Archives of Neurology

Volumn 64, Issue 9, 2007, Pages 1264-1272

  Wachtman, Lynn M ^a,g   Skolasky, Richard L ^a   Tarwater, Patrick M ^c   Esposito, Deneen ^a   Schifitto, Giovanni ^d   Marder, Karen ^e   McDermott, Michael P ^d   Cohen, Bruce A ^f   Nath, Avindra ^a   Sacktor, Ned ^a   Epstein, Leon G ^f   Mankowski, Joseph L ^a   McArthur, Justin C ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE COUNT;

ADULT; AIDS DEMENTIA COMPLEX; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD PLATELETS; CD4 LYMPHOCYTE COUNT; COGNITION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RNA, VIRAL;

EID: 34548640874     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.9.1264     Document Type: Article

References (51)

1. Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ; National HIV Surveillance Committee. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS. 2003;17(10):1539- 1545.
2. McArthur JC. HIV dementia: an evolving disease. J Neuroimmunol. 2004;157(1-2):3-10.
3. McArthur JC, Haughey N, Gartner S, et al. Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol. 2003;9(2):205-221.
4. Chang L, Ernst T, St Hillaire C, Conant K. Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients. Antivir Ther. 2004;9(3):431-440.
5. Conant K, Garzino-Demo A, Nath A, et al. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci U S A. 1998;95(6):3117-3121.
6. Kelder W, McArthur JC, Nance-Sproson T, McClernon DR, Griffen DE. Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol. 1998;44(5):831-835.
7. Conant K, McArthur JC, Griffen DE, Sjulson L, Wahl LM, Irani DN. Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol. 1999;46(3):391-398.
8. Liuzzi GM, Mastroianni CM, Santacroce MP, et al. Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases. J Neurovirol. 2000;6(2):156-163.
9. Mastroianni CM, Paoletti F, Valenti C, Vullo V, Jirillo E, Delia S. Tumor necrosis factor (TNF-alpha) and neurological disorders in HIV infection. J Neurol Neurosurg Psychiatry. 1992;55(3):219-221.
10. Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS. 1999;13(10):1249-1253.
11. Sevigny JJ, Albert SM, McDermott MP, et al. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology. 2004;63(11):2084-2090.
12. Mankowski JL, Clements JE, Zink MC. Searching for clues: tracking the pathogenesis of human immunodeficiency virus central nervous system disease by use of an accelerated, consistent simian immunodeficiency virus macaque model. J Infect Dis. 2002;186(suppl 2):S199-S208.
13. Wachtman LM, Tarwater PM, Queen SE, Adams RJ, Mankowski JL. Platelet decline: an early predictive hematologic marker of simian immunodeficiency virus central nervous system disease. J Neurovirol. 2006;12(1):25-33.
14. Scaradavou A. HIV-related thrombocytopenia. Blood Rev. 2002;16(1):73-76.
15. Ballem PJ, Belzberg A, Devine DV, et al. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N Engl J Med. 1992;327(25):1779-1784.
16. Cole JL, Marzec UM, Gunthel CJ, et al. Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. Blood. 1998;91(9):3239-3246.
17. Najean Y, Rain JD. The mechanism of thrombocytopenia in patients with HIV infection. J Lab Clin Med. 1994;123(3):415-420.
18. Sacktor N, McDermott MP, Marder K, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol. 2002;8(2):136-142.
19. McArthur JC, McDermott MP, McCleron DR, et al. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy [published correction appears in Arch Neurol. 2005;62(7):1110]. Arch Neurol. 2004;61(11):1687-1696.
20. DANA Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1 associated cognitive/motor disorder. Neurology. 1996;47(5):1247-1253.
21. Working Group of the American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection: report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology. 1991;41(6):778-785.
22. Kuter DJ. The physiology of platelet production. Stem Cells. 1996;14(suppl 1):88-101.
23. Stata Statistical Software [computer program]. Version release 8.0. College Station, TX: StataCorp LP; 2003.
24. McArthur JC, Hoover DR, Baceller H, et al. Dementia in AIDS patients: incidence and risk factors: Multicenter AIDS Cohort Study. Neurology. 1993;43(11):2245-2252.
25. Qureshi AI, Hanson DL, Jones JL, Janssen RS. Estimation of the temporal probability of human immunodeficiency virus (HIV) dementia after risk stratification for HIV-infected persons. Neurology. 1998;50(2):392-397.
26. Coyle TE. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Med Clin North Am. 1997;81(2):449-470.
27. Kreuzer KA, Rockstroh JK. Pathogenesis and pathophysiology of anemia in HIV infection. Ann Hematol. 1997;75(5-6):179-187.
28. Spivak JL, Barnes DC, Fuchs E, Quinn TC. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA. 1989;261(21):3104-3107.
29. Bahner I, Kearns K, Coutinho S, Leonard EH, Kohn DB. Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficient for HIV-1-induced hematopoietic suppression in vitro: demonstration by gene modification of primary human stroma. Blood. 1997;90(5):1787- 1798.
30. Lee B, Doranz BJ, Ratajczak MZ, Doms RW. An intricate web: chemokine receptors, HIV-1 and hematopoiesis. Stem Cells. 1998;16(2):79-88.
31. Mankowski JL, Queen SE, Clements JE, Zink MC. Cerebrospinal fluid markers predict SIV CNS disease. J Neuroimmunol. 2004;157(1-2):66-70.
32. Roberts ES, Burudi EM, Flynn C, et al. Acute SIV infection of the brain leads to upregulation of IL6 and interferon-regulated genes: expression patterns throughout disease progression and impact on neuroAIDS. J Neuroimmunol. 2004;157(1-2):81-92.
33. Matsubara K, Nigami H, Harigaya H, et al. Thrombopoietin in the cerebrospinal fluid of patients with aseptic and bacterial meningitis. J Interferon Cytokine Res. 2005;25(4):220-226.
34. Ehrenreich H, Hasselblatt M, Knerlich F, et al. A hematopoietic growth factor, thrombopoietin, has a proapototic role in the brain. Proc Natl Acad Sci U S A. 2005;102(3):862-867.
35. Jurk K, Kehrel BE. Platelets: physiology and biochemistry. Semin Thromb Hemost. 2005;31(4):381-392.
36. Solanki DL, Blackburn BC. Spurious leukocytosis and thrombocytopenia: a dual phenomenon caused by clumping of platelets in vitro. JAMA. 1983;250(18):2514-2515.
37. Holme PA, Muller F, Solum NO, Brosstad F, Froland SS, Aukrust P. Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection. FASEB J. 1998;12(1):79-89.
38. Ahmad R, Menezes J, Knafo L, Ahmad A. Activated human platelets express Fas-L and induce apoptosis in Fas-positive tumor cells. J Leukoc Biol. 2001;69(1):123-128.
39. Weyrich AS, Elstad MR, McEver RP, et al. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest. 1996;97(6):1525-1534.
40. 3 integrin and GP1bα. J Exp Med. 1998;187(3):329-339.
41. Liu L, Kubes P. Molecular mechanisms of leukocyte recruitment: organ-specific mechanisms of action. Thromb Haemost. 2003;89(2):213-220.
42. Elzey BD, Sprague DL, Ratliff TL. The emerging role of platelets in adaptive immunity. Cell Immunol. 2005;238(1):1-9.
43. Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath MS. Unique monocyte subset in patients with AIDS dementia. Lancet. 1997;349(9053):692-695.
44. Gartner S. AIDS: HIV infection and dementia. Science. 2000;287(5453):602-604.
45. Kim WK, Corey S, Alvarez X, Williams K. Monocyte/macrophage traffic in HIV and SIV encephalitis. J Leukoc Biol. 2003;74(5):650-656.
46. Cherner M, Masliah M, Ellis RJ, et al. Neurocognitive dysfunction predicts post-mortem findings of HIV encephalitis. Neurology. 2002;59(10):1563-1567.
47. Satz P, Morgenstern H, Miller EN, et al. Low education as a possible risk factor for cognitive abnormalities in HIV-1: findings from the Multicenter AIDS Cohort Study (MACS). J Acquir Immune Defic Syndr. 1993;6(5):503-511.
48. Camino N, Nunez M, Blanco F, Gonzalez-Requena D, Gonzalez-Lahoz J, Soriano V. Indinavir-induced thrombocytopenia. AIDS Patient Care STDS. 2003;17(3):103-104.
49. Louache F, Vainchenker W. Thrombocytopenia in HIV infection. Curr Opin Hematol. 1994;1(5):369-372.
50. Holt RJ. Neuroleptic drug-induced changes in platelet levels. J Clin Psychopharmacol. 1984;4(3):130-132.
51. Lambertenghi Deliliers G. Blood dyscrasias in clozapine-treated patients in Italy. Haematologica. 2000;85(3):233-237.